Close×

A Colorado micro-distillery asked glass container manufacturer Owens-Illinois to create a bottle that rocks – quite literally.

Called Rocker Spirits, the brand was co-founded by Duston Evans.

He worked with O-I's new product development team on his vision of ensuring the bottle stood out on-shelf.

“I didn’t want to be another square bottle," he said. 

"If I couldn’t have a bottle that rocks, I wasn’t going to get into the spirits industry."

At Evans’ direction, the design team drew inspiration from Americana and the vintage industrial era.

"The goal was for the Rocker brand to transport the consumer back to a simpler time when we made things with our hands and had pride in workmanship and craftsmanship." Evans said. 

"By working with glass, I knew we could make a design that would stand out on-shelf and provide immediate brand identity and recognition."

The design itself was based on a vintage oil can from the 1930s with a tilt feature for ease-of-pouring.

The rounded bottle is made of super-premium flint and is flattened on two sides.

It has a distinctive off-centre neck and finish, and a counterbalanced weighted base that allows it to be rocked forward and back for pouring.

It will provide the brand packaging for Rocker’s full line of spirits – aged rum, whiskey and vodka.

Click here to see a video of how the rocking bottle works.

Food & Drink Business

Australia’s first social enterprise bakery, The Bread & Butter Project, has graduated its latest group of bakers, with its largest ever cohort marking the program’s 100th graduate.

The University of Sydney and Peking University have launched a Joint Centre for Food Security and Sustainable Agricultural Development, which will support research into improving the sustainability and security of food systems in Australia and China.

Sydney-based biotech company, All G, has secured regulatory approval in China to sell recombinant (made from microbes, not cows) lactoferrin. CEO Jan Pacas says All G is the first company in the world to receive the approval, and recombinant human lactoferrin is “next in line”.